tiprankstipranks
Trending News
More News >
Deveron UAS Corp (TSE:FARM)
:FARM
Canadian Market

Deveron UAS (FARM) AI Stock Analysis

Compare
14 Followers

Top Page

TS

Deveron UAS

(FARM)

Rating:40Underperform
Price Target:
Deveron UAS faces significant challenges, including high leverage, negative profitability, and recent revenue declines, impacting its financial performance. Technical indicators suggest limited momentum, while valuation metrics reflect the company's struggles. Corporate events underscore operational and regulatory hurdles, leading to a cautious outlook on the stock.

Deveron UAS (FARM) vs. iShares MSCI Canada ETF (EWC)

Deveron UAS Business Overview & Revenue Model

Company DescriptionDeveron UAS (FARM) is a leading provider in the agricultural technology sector, specializing in the collection and analysis of aerial data to support precision farming. The company utilizes unmanned aerial systems (UAS) to gather high-resolution imagery and data from agricultural fields. This data is then processed and analyzed to provide actionable insights that help farmers optimize crop yields, reduce input costs, and improve overall farm management practices.
How the Company Makes MoneyDeveron UAS generates revenue primarily through its data collection and analysis services offered to farmers and agricultural businesses. The company charges fees for its aerial data collection services, which involve deploying drones to capture detailed imagery of agricultural fields. Additionally, Deveron UAS provides data processing and analytics services, generating further revenue by offering insights and customized reports that assist clients in making informed decisions about their farming operations. Key revenue streams include service contracts with individual farmers, agricultural cooperatives, and partnerships with agribusinesses that integrate Deveron's data solutions into their products or services. The company may also benefit from partnerships with technology providers or agricultural equipment manufacturers that enhance its service offerings or expand its market reach.

Deveron UAS Earnings Call Summary

Earnings Call Date:Feb 28, 2025
(Q3-2024)
|
% Change Since: 0.00%|
Next Earnings Date:Jun 03, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant cost optimizations and growth in the U.S. operations, alongside new enterprise contracts. However, challenges such as the demand letter from A&L and seasonal cash issues were noted. While the highlights indicate strong operational improvements, the presence of significant financial challenges tempers the overall positive outlook.
Q3-2024 Updates
Positive Updates
Cost Optimization Success
Deveron executed $2.5 million in cost optimization, improving non-IFRS adjusted EBITDA loss by 57% year-over-year.
Enterprise Contract Wins
Closed 2 new enterprise contracts with expected sales of USD 1.5 million in 2024, adding 100,000 new samples to the U.S. lab network.
U.S. Operations Growth
U.S. operations achieved 86% year-over-year growth in fertility and 22% growth in carbon testing.
EBITDA Margin Improvement
Experienced a 36% year-over-year EBITDA margin improvement, roughly a $1.9 million enhancement.
Operating Expense Reduction
Operating expenses declined by $1.4 million year-over-year, with significant reductions in travel costs, operational payroll, and other related expenses.
Negative Updates
Demand Letter from A&L
Received a demand letter regarding the prepayment of an unsecured promissory note tied to the acquisition of A&L in May 2022.
Non-Cash Operating Expenses Change
Non-cash operating expenses driven by the change in NCI put obligation resulted in a decrease from a gain of $759,000 to a gain of $318,000 for the quarter.
Seasonal Cash Challenges
Facing seasonal cash crunches, managed internally and with existing investors' help.
Company Guidance
In the Q3 2024 earnings call for Deveron Corp., the company provided guidance highlighting significant improvements and future strategies. Deveron achieved a 57% year-over-year improvement in non-IFRS adjusted EBITDA loss due to $2.5 million in cost optimization efforts implemented previously. The company also reported a 36% year-over-year improvement in EBITDA margin, translating to a $1.9 million increase. Gross margin grew by 8%, aided by the exit from a negative margin carbon collection business. Operating expenses were reduced by $1.4 million year-over-year, while stock-based payments decreased by 58%. Deveron's U.S. fertility operations saw an 86% year-over-year growth, and the company secured two new enterprise contracts projected to generate USD 1.5 million in sales. Additionally, Deveron reported a well over $1 million order book for carbon testing services despite initially budgeting $0 for 2024. The company emphasized a strategic focus on expanding their soil testing services, particularly in the U.S., aiming to leverage operational capacity and enhance testing volume for future growth.

Deveron UAS Financial Statement Overview

Summary
Deveron UAS has demonstrated strong revenue growth but struggles with profitability and financial stability. The company relies heavily on debt, with negative equity posing risks. Despite improvements in cash flow, financial health remains vulnerable, requiring strategic measures to improve profitability and strengthen the balance sheet.
Income Statement
45
Neutral
The company has shown significant revenue growth over the years, with a notable increase in total revenue from 2020 to TTM (2024). However, profitability metrics are concerning, with consistent negative EBIT and net income, indicating operational inefficiencies and challenges in achieving profitability. The gross profit margin remains relatively stable but is overshadowed by the substantial negative net profit margin.
Balance Sheet
30
Negative
The balance sheet reveals a high debt-to-equity ratio due to significant negative stockholders' equity, posing a risk of financial instability. Total liabilities have increased, reflecting potential liquidity challenges. The equity ratio is negative, highlighting a high reliance on debt financing, which could impact future growth and financial flexibility.
Cash Flow
40
Negative
Cash flow analysis shows improvement in free cash flow in TTM (2024) compared to previous years. However, the operating cash flow to net income ratio is weak due to persistent negative net income. While free cash flow has turned positive recently, the overall cash generation remains a concern, limiting the company's ability to fund operations internally.
Breakdown
TTMJun 2024Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
31.43M35.32M28.92M8.60M2.87M2.06M
Gross Profit
20.15M23.61M19.95M5.83M2.24M1.21M
EBIT
-46.04M-59.04M-3.00-4.74M-1.77M-1.80M
EBITDA
-41.21M-43.16M24.12K-3.99M-1.56M-1.76M
Net Income Common Stockholders
-51.68M-57.48M-9.09M-5.18M-1.76M-1.94M
Balance SheetCash, Cash Equivalents and Short-Term Investments
2.17M1.19M5.82M6.87M6.22M1.28M
Total Assets
55.14M56.86M116.73M22.77M9.37M3.86M
Total Debt
44.54M45.85M48.97M1.95M391.25K287.79K
Net Debt
42.37M44.66M43.15M-4.92M-5.83M-990.11K
Total Liabilities
69.80M74.70M72.72M6.46M1.11M736.34K
Stockholders Equity
-40.82M-43.56M19.29M14.68M8.26M3.12M
Cash FlowFree Cash Flow
1.04M3.04M-15.49M-4.73M-1.85M-1.72M
Operating Cash Flow
1.48M4.50M-10.00M-4.22M-1.68M-1.59M
Investing Cash Flow
-122.21K-1.48M-43.45M-4.40M-382.62K-126.60K
Financing Cash Flow
-1.01M-4.78M52.41M9.27M7.00M72.75K

Deveron UAS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.04
Negative
100DMA
0.04
Positive
200DMA
0.04
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
28.99
Positive
STOCH
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:FARM, the sentiment is Negative. The current price of 0.04 is equal to the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 28.99 is Positive, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:FARM.

Deveron UAS Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSDRX
75
Outperform
C$247.59M5.2529.02%0.45%-19.66%15.33%
65
Neutral
$8.92B15.034.68%6.11%3.59%-2.49%
TSKWE
49
Neutral
$5.42M-231.01%121.88%77.93%
TSNPK
47
Neutral
C$25.54M-32.62%-39.06%-9.07%
41
Neutral
$5.21M260.66%
40
Underperform
C$8.31M
-15.73%-45.92%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:FARM
Deveron UAS
0.04
-0.03
-42.86%
TSE:VSBY
Vsblty Groupe Technologies
0.10
0.02
17.65%
TSE:DRX
ADF Group Inc. SV
8.62
-9.06
-51.24%
TSE:NPK
Verde Agritech
0.53
-0.40
-43.01%
TSE:KWE
KWESST Micro Systems
8.90
-144.40
-94.19%

Deveron UAS Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Deveron Corp. Secures Forbearance Agreement with TD Bank
Neutral
Apr 28, 2025

Deveron Corp. has entered into a forbearance agreement with Toronto Dominion Bank concerning a $26 million loan, allowing the bank to refrain from exercising its rights due to certain defaults until September 30, 2025, or upon specific termination events. This agreement supports Deveron’s strategic review process to explore alternatives for meeting short-term liquidity needs, potentially impacting its operations and market positioning.

Spark’s Take on TSE:FARM Stock

According to Spark, TipRanks’ AI Analyst, TSE:FARM is a Underperform.

Deveron UAS faces significant challenges, including high leverage, negative profitability, and recent revenue declines, impacting its financial performance. Technical indicators suggest limited momentum, while valuation metrics reflect the company’s struggles. Corporate events underscore operational and regulatory hurdles, leading to a cautious outlook on the stock.

To see Spark’s full report on TSE:FARM stock, click here.

Executive/Board ChangesBusiness Operations and Strategy
Deveron Corp. Announces Director Resignation Amidst Strategic Focus
Neutral
Apr 8, 2025

Deveron Corp. announced the resignation of Mr. Albert Contardi from its board of directors, effective immediately. The company expressed gratitude for his contributions and wished him success in future endeavors. This change in leadership comes as Deveron continues to focus on its core mission of enhancing agricultural productivity through technology-driven insights, potentially impacting its strategic direction and stakeholder relations.

Spark’s Take on TSE:FARM Stock

According to Spark, TipRanks’ AI Analyst, TSE:FARM is a Underperform.

Deveron UAS’s overall stock score is low due to significant financial challenges, including high debt levels and ongoing losses. Although revenue growth is a positive aspect, it is overshadowed by the company’s precarious financial health and lack of profitability. The stable technical indicators and poor valuation metrics further contribute to the overall low score.

To see Spark’s full report on TSE:FARM stock, click here.

Business Operations and StrategyFinancial Disclosures
Deveron Corp. Faces Revenue Decline Amid Market Challenges
Negative
Feb 28, 2025

Deveron Corp. reported a decrease in revenue and adjusted EBITDA for the second quarter of fiscal 2025, attributed to softer sales in its Canadian fertility and specialty tissue products, macroeconomic challenges in the North American agricultural sector, and the company’s exit from its unprofitable carbon business. Operating expenses were reduced by 22% due to cost optimization and headcount reductions, reflecting the company’s efforts to streamline operations amidst challenging market conditions.

Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Deveron Corp. Reports 2024 Financial Results, Records Impairment Charge
Negative
Feb 18, 2025

Deveron Corp. has released its audited financial results for the year ending June 2024 and the quarter ending September 2024. The company experienced a slight decline in revenue by 3.5% for the year, but saw a significant improvement in Adjusted EBITDA, which increased by 347%. However, the company recorded an impairment charge of $43,132,423, attributed mainly to goodwill from the acquisition of lab testing businesses. Additionally, Deveron’s financial performance was impacted by seasonal tissue volumes and the exit from the US carbon service business. The company is working with the Ontario Securities Commission to address a review of its continuous disclosure after being subjected to a cease trade order for more than 120 days.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.